Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Ivor Douglas

Concepts (600)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Respiration, Artificial
23
2024
529
3.960
 Why?
Sepsis
19
2024
509
2.900
 Why?
Respiratory Insufficiency
12
2023
290
2.420
 Why?
Fluid Therapy
11
2024
123
2.360
 Why?
Critical Care
18
2024
476
2.320
 Why?
Intensive Care Units
23
2024
617
2.230
 Why?
Critical Illness
20
2024
646
2.180
 Why?
Tracheostomy
5
2024
101
1.870
 Why?
Shock, Septic
11
2024
186
1.680
 Why?
Hospital Mortality
19
2024
776
1.620
 Why?
Shock
3
2024
84
1.480
 Why?
Hospitals
6
2023
581
1.350
 Why?
Pneumonia
7
2023
568
1.230
 Why?
Hypotension
4
2024
116
1.050
 Why?
Resuscitation Orders
3
2023
45
1.050
 Why?
Multiple Organ Failure
4
2024
146
0.990
 Why?
Humans
132
2025
114686
0.950
 Why?
Patient Readmission
6
2021
610
0.920
 Why?
Vasoconstrictor Agents
5
2023
112
0.890
 Why?
Middle Aged
55
2025
26737
0.890
 Why?
Ultrasonography, Doppler
1
2024
105
0.880
 Why?
Aged
42
2025
19074
0.860
 Why?
Pneumonia, Ventilator-Associated
2
2015
40
0.840
 Why?
Resuscitation
8
2024
252
0.790
 Why?
Safety-net Providers
3
2023
95
0.790
 Why?
Hemodynamics
3
2024
1012
0.780
 Why?
Extracorporeal Membrane Oxygenation
2
2023
241
0.770
 Why?
Hospitals, High-Volume
2
2019
39
0.770
 Why?
Severity of Illness Index
6
2021
2539
0.770
 Why?
Retrospective Studies
30
2024
12550
0.760
 Why?
Patient Acceptance of Health Care
5
2021
681
0.750
 Why?
Male
70
2025
55596
0.740
 Why?
Monitoring, Physiologic
4
2024
249
0.740
 Why?
Frailty
1
2023
115
0.730
 Why?
Patient Positioning
1
2021
42
0.720
 Why?
Diabetes Insipidus
1
2020
7
0.700
 Why?
Practice Guidelines as Topic
6
2021
1395
0.690
 Why?
Substance Withdrawal Syndrome
3
2021
159
0.650
 Why?
Hospitals, Low-Volume
1
2019
22
0.640
 Why?
Adult
43
2025
30550
0.630
 Why?
Female
61
2025
59507
0.620
 Why?
Dyspnea
2
2021
211
0.620
 Why?
Diabetes Mellitus
2
2020
900
0.590
 Why?
Alcoholism
5
2021
713
0.560
 Why?
Ventilator-Induced Lung Injury
3
2018
49
0.550
 Why?
California
5
2022
353
0.540
 Why?
Neoplasms
3
2023
2097
0.540
 Why?
Randomized Controlled Trials as Topic
11
2024
1214
0.540
 Why?
Microbiological Techniques
1
2016
29
0.520
 Why?
Pulmonary Medicine
3
2015
87
0.520
 Why?
Sleep Medicine Specialty
1
2015
9
0.510
 Why?
Acute Kidney Injury
7
2023
638
0.510
 Why?
Acute Lung Injury
6
2023
299
0.490
 Why?
Ethanol
2
2021
538
0.490
 Why?
Molecular Diagnostic Techniques
1
2016
91
0.490
 Why?
Health Policy
4
2024
334
0.490
 Why?
Hyperemia
3
2024
45
0.480
 Why?
Research Design
9
2023
928
0.470
 Why?
Cohort Studies
11
2023
4895
0.460
 Why?
Aged, 80 and over
12
2025
6347
0.450
 Why?
Pulmonary Disease, Chronic Obstructive
7
2017
916
0.440
 Why?
Renin-Angiotensin System
2
2025
72
0.440
 Why?
Prone Position
3
2021
27
0.430
 Why?
Bronchoalveolar Lavage Fluid
2
2016
590
0.430
 Why?
Inpatients
3
2023
380
0.430
 Why?
Receptor, EphA2
3
2018
19
0.430
 Why?
Cause of Death
3
2015
361
0.420
 Why?
Immune Tolerance
1
2015
323
0.420
 Why?
Nicotinic Agonists
1
2014
100
0.410
 Why?
Laryngoscopes
2
2023
38
0.410
 Why?
Dual Specificity Phosphatase 1
1
2012
28
0.400
 Why?
Cross Infection
5
2020
197
0.400
 Why?
Noninvasive Ventilation
3
2017
32
0.400
 Why?
Marijuana Smoking
1
2015
224
0.400
 Why?
Lung
12
2018
3561
0.400
 Why?
Apoptosis
6
2014
2363
0.390
 Why?
Pulmonary Fibrosis
4
2017
323
0.390
 Why?
Hospitalization
9
2025
1752
0.390
 Why?
Tobacco Use Disorder
1
2014
234
0.380
 Why?
Immunity, Innate
1
2017
720
0.380
 Why?
Prospective Studies
12
2024
6220
0.380
 Why?
Nicotine
1
2014
265
0.380
 Why?
Lipopolysaccharides
4
2017
823
0.380
 Why?
Organ Dysfunction Scores
2
2024
39
0.370
 Why?
Drug Delivery Systems
1
2014
296
0.370
 Why?
Child Development
1
2015
385
0.370
 Why?
Protein C
5
2012
45
0.360
 Why?
Tissue Plasminogen Activator
2
2024
225
0.360
 Why?
Delirium
2
2024
66
0.360
 Why?
Glycosaminoglycans
3
2016
79
0.360
 Why?
Emergency Service, Hospital
5
2024
1815
0.350
 Why?
Long-Term Care
2
2022
78
0.350
 Why?
United States
18
2024
12183
0.340
 Why?
Length of Stay
6
2024
962
0.340
 Why?
Smoking Cessation
1
2014
374
0.340
 Why?
Treatment Outcome
15
2024
9088
0.340
 Why?
Antipsychotic Agents
2
2024
184
0.330
 Why?
Public Health
1
2014
433
0.330
 Why?
Comorbidity
4
2022
1448
0.330
 Why?
Metabolic Syndrome
2
2023
321
0.330
 Why?
Vena Cava, Inferior
3
2024
56
0.320
 Why?
Cannabis
1
2015
384
0.320
 Why?
Ephrin-A1
3
2018
4
0.320
 Why?
Biomarkers
7
2023
3408
0.320
 Why?
Intubation, Intratracheal
4
2024
216
0.310
 Why?
Lipid A
2
2014
28
0.310
 Why?
Societies, Medical
7
2021
664
0.310
 Why?
Institutional Practice
1
2008
3
0.310
 Why?
Anti-Bacterial Agents
1
2017
1481
0.300
 Why?
Odds Ratio
6
2019
953
0.300
 Why?
Personnel Staffing and Scheduling
1
2008
79
0.290
 Why?
Pandemics
4
2024
1317
0.290
 Why?
Betacoronavirus
2
2020
250
0.290
 Why?
Neutrophils
3
2024
1176
0.290
 Why?
Integrins
1
2007
79
0.280
 Why?
Pulmonary Alveolar Proteinosis
1
2007
16
0.280
 Why?
Neovascularization, Pathologic
2
2007
281
0.280
 Why?
Renal Insufficiency, Chronic
2
2024
486
0.280
 Why?
MAP Kinase Signaling System
2
2014
276
0.270
 Why?
Lung Injury
3
2016
198
0.270
 Why?
Patient Admission
2
2023
176
0.270
 Why?
Ultrasonography
3
2024
634
0.270
 Why?
Hyponatremia
1
2006
37
0.260
 Why?
Double-Blind Method
9
2024
1660
0.260
 Why?
Lung Diseases, Obstructive
1
2006
40
0.260
 Why?
Leukocytes
1
2007
276
0.260
 Why?
Medicaid
3
2021
407
0.250
 Why?
Treatment Failure
7
2024
331
0.250
 Why?
Biomedical Research
3
2021
585
0.250
 Why?
Pneumonia, Viral
2
2020
338
0.250
 Why?
Coronavirus Infections
2
2020
330
0.250
 Why?
Laryngoscopy
2
2023
91
0.250
 Why?
Academic Medical Centers
3
2021
411
0.250
 Why?
Chemokines, CXC
1
2005
60
0.240
 Why?
Bronchi
1
2006
232
0.240
 Why?
Regeneration
1
2006
160
0.240
 Why?
Bronchiectasis
1
2006
106
0.240
 Why?
Oxazines
1
2024
25
0.240
 Why?
Bronchiolitis Obliterans
1
2005
66
0.240
 Why?
Succinylcholine
1
2024
7
0.240
 Why?
Adrenal Insufficiency
2
2013
26
0.240
 Why?
Infusions, Intravenous
5
2024
371
0.240
 Why?
Methylprednisolone
1
2005
81
0.230
 Why?
Hypoxia
3
2024
958
0.230
 Why?
Respiratory Mucosa
1
2006
251
0.230
 Why?
Venous Pressure
1
2024
8
0.230
 Why?
Phagocytosis
1
2006
350
0.230
 Why?
Patient Protection and Affordable Care Act
2
2016
99
0.230
 Why?
Cytokines
7
2017
1841
0.230
 Why?
Risk Factors
10
2021
8632
0.230
 Why?
Morpholines
1
2024
102
0.230
 Why?
Plasminogen
1
2024
33
0.230
 Why?
Vasopressins
3
2021
56
0.230
 Why?
Anti-Infective Agents
4
2012
225
0.220
 Why?
Leukocyte Elastase
1
2024
80
0.220
 Why?
beta Catenin
1
2005
219
0.220
 Why?
Renal Dialysis
4
2023
374
0.220
 Why?
Plasminogen Activator Inhibitor 1
1
2024
83
0.220
 Why?
Atrial Pressure
1
2023
4
0.220
 Why?
Receptor, Angiotensin, Type 1
1
2023
20
0.220
 Why?
Diterpenes
2
2014
31
0.210
 Why?
Craniocerebral Trauma
1
2005
134
0.210
 Why?
Area Under Curve
3
2020
274
0.210
 Why?
Lung Diseases
3
2016
701
0.210
 Why?
Haloperidol
2
2024
35
0.210
 Why?
Analgesics, Non-Narcotic
1
2024
120
0.210
 Why?
Hemodynamic Monitoring
1
2022
1
0.210
 Why?
Fibrosis
1
2005
453
0.210
 Why?
Thiazoles
2
2024
110
0.210
 Why?
Fibrinolysis
1
2024
158
0.200
 Why?
Evidence-Based Medicine
5
2016
668
0.200
 Why?
Clinical Decision-Making
1
2024
268
0.190
 Why?
Early Diagnosis
4
2017
217
0.190
 Why?
Transportation
1
2022
44
0.190
 Why?
Acetaminophen
1
2024
241
0.190
 Why?
Hydrocortisone
1
2003
267
0.190
 Why?
Logistic Models
7
2017
1841
0.190
 Why?
Pyridines
1
2024
425
0.190
 Why?
Stroke Volume
1
2024
504
0.190
 Why?
Vasodilator Agents
1
2023
302
0.190
 Why?
Heart Arrest
2
2021
292
0.180
 Why?
Receptors, Interleukin-6
1
2021
34
0.180
 Why?
Central Nervous System Depressants
1
2021
81
0.180
 Why?
Piperazines
2
2024
309
0.180
 Why?
Internship and Residency
2
2019
926
0.180
 Why?
Hospital Charges
1
2020
39
0.180
 Why?
Animals
20
2018
31706
0.180
 Why?
Community-Acquired Infections
3
2020
141
0.180
 Why?
Reproducibility of Results
5
2024
2764
0.180
 Why?
Rib Fractures
1
2020
25
0.180
 Why?
Health Priorities
1
2020
34
0.180
 Why?
Glucocorticoids
1
2005
532
0.180
 Why?
Hydroxychloroquine
1
2020
54
0.180
 Why?
Heart Failure
3
2023
1945
0.170
 Why?
Cell Proliferation
2
2014
2187
0.170
 Why?
Mice, Inbred C57BL
9
2018
4694
0.170
 Why?
Antigens, Differentiation
1
2000
79
0.170
 Why?
Patient Selection
1
2023
641
0.170
 Why?
Patient Handoff
1
2019
26
0.170
 Why?
Risk Adjustment
1
2020
76
0.160
 Why?
Age Factors
4
2019
2894
0.160
 Why?
Blood Glucose Self-Monitoring
1
2023
505
0.160
 Why?
Cell Adhesion Molecules
1
2000
168
0.160
 Why?
Hospital Costs
1
2019
104
0.160
 Why?
Combined Modality Therapy
2
2020
1121
0.160
 Why?
Dopamine Antagonists
1
2018
22
0.160
 Why?
Health Services Accessibility
4
2020
763
0.160
 Why?
ROC Curve
1
2020
442
0.150
 Why?
Thrombosis
1
2021
298
0.150
 Why?
Orthopedic Procedures
1
2020
208
0.150
 Why?
Antimicrobial Stewardship
1
2020
94
0.150
 Why?
Blood Glucose
2
2023
1828
0.150
 Why?
Eosinophils
1
2000
278
0.150
 Why?
Predictive Value of Tests
4
2016
1796
0.150
 Why?
Optometry
1
2017
2
0.150
 Why?
Mice
13
2017
14869
0.140
 Why?
Guideline Adherence
2
2014
490
0.140
 Why?
Platelet Count
2
2014
81
0.140
 Why?
Tidal Volume
2
2014
75
0.140
 Why?
Cell Adhesion
4
2012
432
0.140
 Why?
Pyrimidines
2
2024
376
0.140
 Why?
Lymphocyte Count
1
2017
133
0.140
 Why?
Cystic Fibrosis
1
2006
955
0.140
 Why?
Analysis of Variance
1
2020
1226
0.140
 Why?
Transients and Migrants
1
2017
22
0.140
 Why?
Attitude of Health Personnel
3
2019
975
0.140
 Why?
Antibodies, Monoclonal, Humanized
1
2021
663
0.130
 Why?
Tretinoin
1
2017
122
0.130
 Why?
Delivery of Health Care
1
2023
833
0.130
 Why?
Clinical Trials as Topic
1
2021
932
0.130
 Why?
Burnout, Professional
1
2021
322
0.130
 Why?
Nephrectomy
2
2008
150
0.130
 Why?
Ventricular Function, Right
1
2018
250
0.130
 Why?
Continuity of Patient Care
1
2018
253
0.130
 Why?
Health Insurance Exchanges
1
2016
2
0.130
 Why?
Sleep Wake Disorders
2
2017
233
0.130
 Why?
Risk Management
1
2017
89
0.130
 Why?
Breath Tests
1
2016
82
0.130
 Why?
Ventricular Dysfunction, Right
1
2018
217
0.130
 Why?
Staphylococcus aureus
2
2011
389
0.130
 Why?
Respiratory Tract Diseases
1
2017
138
0.120
 Why?
Prognosis
5
2021
3329
0.120
 Why?
Quality of Life
2
2024
2353
0.120
 Why?
Research
1
2018
394
0.120
 Why?
Patient Care Team
1
2019
517
0.120
 Why?
Survival Analysis
4
2014
1211
0.120
 Why?
Marriage
1
2016
106
0.120
 Why?
Alcohol Withdrawal Seizures
1
2014
1
0.120
 Why?
Bronchoalveolar Lavage
1
2015
84
0.120
 Why?
Risk Assessment
5
2015
2968
0.120
 Why?
Alcohol Withdrawal Delirium
1
2014
8
0.120
 Why?
Automation
1
2015
74
0.120
 Why?
Multicenter Studies as Topic
3
2023
249
0.120
 Why?
Bacteriological Techniques
1
2015
65
0.120
 Why?
Physicians
2
2021
772
0.120
 Why?
5-Lipoxygenase-Activating Protein Inhibitors
1
2014
1
0.120
 Why?
5-Lipoxygenase-Activating Proteins
1
2014
5
0.120
 Why?
Education, Medical
1
2017
215
0.120
 Why?
Catheterization, Central Venous
1
2015
83
0.120
 Why?
Fluorobenzenes
1
2014
11
0.120
 Why?
Leukotrienes
1
2014
35
0.120
 Why?
Phenanthrenes
1
2014
10
0.120
 Why?
Poverty
2
2016
442
0.110
 Why?
APACHE
2
2011
58
0.110
 Why?
CD4-Positive T-Lymphocytes
1
2000
959
0.110
 Why?
Down-Regulation
2
2017
594
0.110
 Why?
Potassium
1
2014
128
0.110
 Why?
Alanine Transaminase
1
2014
141
0.110
 Why?
Systemic Inflammatory Response Syndrome
1
2014
72
0.110
 Why?
Microscopy
1
2015
125
0.110
 Why?
Kaplan-Meier Estimate
5
2018
811
0.110
 Why?
Angiotensin II
2
2025
87
0.110
 Why?
Laryngeal Masks
1
2013
13
0.110
 Why?
Quinolines
1
2014
129
0.110
 Why?
Time Factors
7
2023
6115
0.100
 Why?
Health Knowledge, Attitudes, Practice
2
2024
1183
0.100
 Why?
Patient Discharge
1
2018
772
0.100
 Why?
Sensitivity and Specificity
2
2015
1692
0.100
 Why?
Cisplatin
1
2014
262
0.100
 Why?
Physician-Patient Relations
1
2017
462
0.100
 Why?
Glycocalyx
1
2012
18
0.100
 Why?
Patient-Centered Care
1
2017
473
0.100
 Why?
Acute Disease
3
2016
911
0.100
 Why?
Oxygen
3
2023
854
0.100
 Why?
Follow-Up Studies
5
2024
4411
0.100
 Why?
Supine Position
1
2012
32
0.100
 Why?
Indoles
1
2014
304
0.100
 Why?
Insurance, Health
1
2014
244
0.100
 Why?
Biomarkers, Pharmacological
1
2012
26
0.100
 Why?
Data Interpretation, Statistical
2
2011
321
0.100
 Why?
I-kappa B Proteins
1
2012
79
0.100
 Why?
Health Status
1
2017
722
0.100
 Why?
Clinical Alarms
1
2011
10
0.100
 Why?
Data Display
1
2011
19
0.100
 Why?
Endotoxemia
1
2012
86
0.100
 Why?
Adrenergic beta-2 Receptor Agonists
1
2011
32
0.090
 Why?
Albuterol
1
2011
102
0.090
 Why?
Genetic Markers
1
2012
320
0.090
 Why?
Sulfonamides
1
2014
445
0.090
 Why?
Fibrinolytic Agents
2
2024
234
0.090
 Why?
Decision Making
1
2017
782
0.090
 Why?
Interferons
1
2011
151
0.090
 Why?
Peroxidase
2
2008
163
0.090
 Why?
Alcohol-Related Disorders
1
2011
113
0.090
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2014
373
0.090
 Why?
Recombinant Proteins
5
2012
1230
0.090
 Why?
Survival Rate
3
2015
1644
0.090
 Why?
Stenotrophomonas maltophilia
1
2009
2
0.090
 Why?
Disease Models, Animal
5
2018
3535
0.090
 Why?
Clinical Protocols
2
2012
233
0.090
 Why?
Thoracic Diseases
1
2009
13
0.090
 Why?
Databases, Factual
2
2016
1125
0.080
 Why?
Cell Movement
3
2011
869
0.080
 Why?
Ligands
2
2023
562
0.080
 Why?
Adrenal Cortex Hormones
1
2013
497
0.080
 Why?
Gram-Negative Bacterial Infections
1
2009
37
0.080
 Why?
Symptom Assessment
2
2020
119
0.080
 Why?
Blotting, Western
1
2012
1147
0.080
 Why?
Polymerase Chain Reaction
1
2012
993
0.080
 Why?
Cues
1
2011
300
0.080
 Why?
Up-Regulation
1
2012
808
0.080
 Why?
Confidence Intervals
1
2010
305
0.080
 Why?
Age Distribution
1
2010
342
0.080
 Why?
Wounds and Injuries
1
2016
749
0.080
 Why?
Sex Distribution
1
2010
337
0.080
 Why?
Pancreatitis
1
2009
107
0.080
 Why?
Healthcare Disparities
1
2014
480
0.080
 Why?
Pneumonia, Bacterial
1
2009
106
0.080
 Why?
Pulmonary Alveoli
2
2012
373
0.080
 Why?
Incidence
1
2014
2313
0.080
 Why?
Models, Statistical
1
2012
599
0.080
 Why?
Work Schedule Tolerance
1
2008
35
0.080
 Why?
Clinical Trials, Phase III as Topic
2
2023
82
0.070
 Why?
Child, Preschool
2
2015
9116
0.070
 Why?
United Kingdom
1
2008
226
0.070
 Why?
Disease Progression
4
2017
2380
0.070
 Why?
Clinical Competence
1
2014
893
0.070
 Why?
Interleukin-6
2
2008
676
0.070
 Why?
Signal Transduction
4
2018
4513
0.070
 Why?
Rats, Sprague-Dawley
1
2012
2218
0.070
 Why?
Workload
1
2008
132
0.070
 Why?
Flavonoids
1
2007
66
0.070
 Why?
Mandatory Programs
1
2007
15
0.070
 Why?
Carcinoma, Non-Small-Cell Lung
1
1995
961
0.070
 Why?
Pulmonary Emphysema
2
2007
272
0.070
 Why?
Enzyme-Linked Immunosorbent Assay
2
2024
797
0.070
 Why?
Adolescent
5
2025
17844
0.070
 Why?
Demeclocycline
1
2006
3
0.070
 Why?
Mice, Inbred C3H
1
2007
239
0.070
 Why?
Young Adult
5
2025
10469
0.070
 Why?
Methicillin Resistance
1
2006
18
0.070
 Why?
Lithium Compounds
1
2006
9
0.070
 Why?
Sex Factors
3
2018
1715
0.070
 Why?
Mitogen-Activated Protein Kinase 3
1
2007
146
0.070
 Why?
Mitogen-Activated Protein Kinase 1
1
2007
164
0.070
 Why?
Rats
2
2012
4958
0.070
 Why?
Diuretics
1
2006
66
0.070
 Why?
Receptors, Antigen, T-Cell, gamma-delta
1
2006
97
0.070
 Why?
Hospitals, Urban
2
2018
127
0.070
 Why?
Mesoderm
1
2007
138
0.070
 Why?
Protein Kinase Inhibitors
2
2024
785
0.070
 Why?
Hospital Information Systems
1
2006
13
0.070
 Why?
History, 20th Century
2
2017
264
0.070
 Why?
Hypertension, Pulmonary
2
2007
1729
0.070
 Why?
Intercellular Adhesion Molecule-1
2
2012
154
0.070
 Why?
Mice, Inbred BALB C
2
2005
1144
0.060
 Why?
Radiography, Thoracic
1
2007
150
0.060
 Why?
Occupational Health
1
2008
165
0.060
 Why?
Heparin
1
2007
224
0.060
 Why?
Butylated Hydroxytoluene
1
2005
31
0.060
 Why?
Asparagine
1
2005
29
0.060
 Why?
Vocabulary
1
2006
41
0.060
 Why?
Gene Expression Profiling
1
2012
1518
0.060
 Why?
Gene Expression Regulation
2
2012
2320
0.060
 Why?
Cyclin D1
1
2005
61
0.060
 Why?
Emphysema
1
2006
107
0.060
 Why?
Venous Thrombosis
1
2007
140
0.060
 Why?
Cell Line, Transformed
1
2005
133
0.060
 Why?
Medical Order Entry Systems
1
2006
41
0.060
 Why?
Caspase Inhibitors
1
2005
78
0.060
 Why?
Blood Vessels
1
2007
180
0.060
 Why?
Macrophages
2
2014
1263
0.060
 Why?
Angiotensin I
1
2025
5
0.060
 Why?
Ischemia
1
2008
362
0.060
 Why?
Bronchoscopy
1
2007
245
0.060
 Why?
Necrosis
1
2005
211
0.060
 Why?
Androstanols
1
2024
5
0.060
 Why?
Neuromuscular Depolarizing Agents
1
2024
5
0.060
 Why?
Neuromuscular Nondepolarizing Agents
1
2024
8
0.060
 Why?
Colorado
4
2017
4099
0.060
 Why?
HMGB1 Protein
1
2005
48
0.060
 Why?
Diabetic Ketoacidosis
1
2007
159
0.060
 Why?
Hope
1
2024
13
0.060
 Why?
Neuromuscular Blocking Agents
1
2024
24
0.060
 Why?
Pyridazines
1
2024
46
0.060
 Why?
Caspases
1
2005
245
0.060
 Why?
Cadherins
1
2005
175
0.060
 Why?
Practice Patterns, Physicians'
3
2024
1177
0.060
 Why?
T-Lymphocyte Subsets
1
2006
383
0.060
 Why?
Renal Replacement Therapy
1
2024
66
0.060
 Why?
Medicago
1
2023
1
0.060
 Why?
Mental Health
2
2022
562
0.060
 Why?
Steroids
2
2021
144
0.060
 Why?
Uncertainty
1
2024
95
0.060
 Why?
Pleural Effusion
1
2024
47
0.060
 Why?
Enzyme Inhibitors
1
2007
750
0.060
 Why?
Atrial Function, Right
1
2023
12
0.050
 Why?
Angiotensins
1
2023
10
0.050
 Why?
Inflammatory Bowel Diseases
1
2007
284
0.050
 Why?
Autoimmune Diseases
1
2006
382
0.050
 Why?
Collagen
1
2005
415
0.050
 Why?
Antineoplastic Agents
1
2014
1879
0.050
 Why?
Multivariate Analysis
2
2017
1430
0.050
 Why?
Heparitin Sulfate
2
2014
39
0.050
 Why?
Biopsy
1
2007
1036
0.050
 Why?
Drug Administration Schedule
2
2018
718
0.050
 Why?
Decision Support Techniques
2
2020
355
0.050
 Why?
Anticoagulants
1
2007
550
0.050
 Why?
Homeostasis
1
2006
573
0.050
 Why?
Child
2
2015
18414
0.050
 Why?
Diagnosis, Differential
1
2007
1342
0.050
 Why?
Video Recording
1
2023
143
0.050
 Why?
Lung Neoplasms
1
1995
2177
0.050
 Why?
Staphylococcal Infections
1
2006
340
0.050
 Why?
Hemoglobins
1
2024
315
0.050
 Why?
Infant
1
2015
7963
0.050
 Why?
Creatinine
2
2015
425
0.050
 Why?
Endothelial Cells
1
2007
687
0.050
 Why?
p38 Mitogen-Activated Protein Kinases
2
2014
260
0.050
 Why?
Partial Thromboplastin Time
1
2021
51
0.050
 Why?
Lung Diseases, Interstitial
1
2007
508
0.050
 Why?
Oligopeptides
1
2023
236
0.050
 Why?
Perioperative Care
1
2022
127
0.050
 Why?
Electrocardiography
1
2024
560
0.050
 Why?
Peptide Fragments
1
2025
666
0.050
 Why?
Antibodies
2
2018
371
0.050
 Why?
Hemorrhage
1
2005
620
0.040
 Why?
Leukotriene C4
1
2000
12
0.040
 Why?
Chronic Disease
1
2006
1578
0.040
 Why?
CD18 Antigens
1
2000
33
0.040
 Why?
N-Formylmethionine Leucyl-Phenylalanine
1
2000
65
0.040
 Why?
Glasgow Coma Scale
1
2020
153
0.040
 Why?
CD11 Antigens
1
2000
30
0.040
 Why?
Drug Resistance, Microbial
1
2020
66
0.040
 Why?
Costs and Cost Analysis
1
2020
196
0.040
 Why?
Epithelial Cells
1
2005
951
0.040
 Why?
Surveys and Questionnaires
3
2021
4623
0.040
 Why?
Needs Assessment
1
2021
314
0.040
 Why?
Oxidative Stress
1
2005
1076
0.040
 Why?
Smoking
1
2006
1383
0.040
 Why?
Flow Cytometry
2
2017
1083
0.040
 Why?
Algorithms
1
2006
1469
0.040
 Why?
Aftercare
1
2001
186
0.040
 Why?
Hospitals, University
1
2019
172
0.040
 Why?
NF-kappa B
2
2018
641
0.040
 Why?
T-Lymphocytes
1
2006
1737
0.040
 Why?
Mice, Knockout
3
2012
2570
0.040
 Why?
Infection Control
1
2020
135
0.040
 Why?
Adjuvants, Immunologic
1
2000
206
0.040
 Why?
Injury Severity Score
1
2020
499
0.040
 Why?
Class Ib Phosphatidylinositol 3-Kinase
1
2018
2
0.040
 Why?
Linear Models
1
2020
768
0.040
 Why?
Trauma Centers
1
2020
362
0.040
 Why?
Ribosomal Protein S6 Kinases, 70-kDa
1
2018
36
0.040
 Why?
Family
1
2022
589
0.040
 Why?
Mortality
1
2019
287
0.040
 Why?
Victoria
1
2017
15
0.040
 Why?
Antigens, CD
1
2000
442
0.040
 Why?
History, 17th Century
1
2017
15
0.040
 Why?
History, 16th Century
1
2017
14
0.040
 Why?
History, 15th Century
1
2017
11
0.040
 Why?
Recovery of Function
1
2021
574
0.040
 Why?
Cross-Sectional Studies
2
2021
4409
0.040
 Why?
History, Ancient
1
2017
48
0.040
 Why?
United Arab Emirates
1
2017
5
0.040
 Why?
History, Medieval
1
2017
40
0.030
 Why?
Drug Therapy, Combination
2
2012
951
0.030
 Why?
Critical Care Outcomes
1
2016
12
0.030
 Why?
History, 21st Century
1
2017
159
0.030
 Why?
Refugees
1
2017
54
0.030
 Why?
Probability
1
2017
289
0.030
 Why?
Lymphocyte Activation
1
2000
1037
0.030
 Why?
Trauma Severity Indices
1
2016
114
0.030
 Why?
Proto-Oncogene Proteins c-akt
1
2018
398
0.030
 Why?
Anxiety
1
2022
840
0.030
 Why?
Pilot Projects
1
2019
1373
0.030
 Why?
Uteroglobin
1
2014
16
0.030
 Why?
Socioeconomic Factors
1
2018
1078
0.030
 Why?
Cost-Benefit Analysis
1
2017
544
0.030
 Why?
Chemokine CXCL2
1
2014
41
0.030
 Why?
Arachidonate 5-Lipoxygenase
1
2014
45
0.030
 Why?
Rosuvastatin Calcium
1
2014
17
0.030
 Why?
Nitrates
1
2014
72
0.030
 Why?
MAP Kinase Kinase 4
1
2014
23
0.030
 Why?
Nitrites
1
2014
75
0.030
 Why?
Risk
1
2017
812
0.030
 Why?
Creatine Kinase
1
2014
75
0.030
 Why?
Quality Indicators, Health Care
1
2017
287
0.030
 Why?
Epoxy Compounds
1
2014
31
0.030
 Why?
Quality Improvement
1
2021
950
0.030
 Why?
Chondroitin Sulfates
1
2014
33
0.030
 Why?
Liver Failure
1
2014
75
0.030
 Why?
Leukocyte Count
1
2014
293
0.030
 Why?
Toll-Like Receptor 2
1
2014
110
0.030
 Why?
Kidney Function Tests
1
2014
140
0.030
 Why?
Depression
1
2022
1134
0.030
 Why?
Manikins
1
2013
24
0.030
 Why?
Chromatography, Liquid
1
2015
347
0.030
 Why?
Bronchial Spasm
1
2013
4
0.030
 Why?
Cryptogenic Organizing Pneumonia
1
2013
17
0.030
 Why?
Mass Spectrometry
1
2016
633
0.030
 Why?
Contraindications
1
2013
85
0.030
 Why?
Anesthesiology
1
2013
35
0.030
 Why?
Tandem Mass Spectrometry
1
2015
411
0.030
 Why?
Protein C Deficiency
1
2012
2
0.030
 Why?
Connective Tissue Diseases
1
2013
71
0.030
 Why?
Glucuronidase
1
2012
42
0.030
 Why?
Cells, Cultured
1
2000
3886
0.030
 Why?
Knowledge Bases
1
2012
17
0.030
 Why?
Renal Insufficiency
1
2014
137
0.030
 Why?
Intestinal Perforation
1
2012
39
0.030
 Why?
Receptors, Tumor Necrosis Factor, Type I
1
2012
73
0.020
 Why?
Quality of Health Care
1
2017
573
0.020
 Why?
Triage
1
2014
199
0.020
 Why?
Disease Management
1
2016
560
0.020
 Why?
Water-Electrolyte Balance
1
2011
26
0.020
 Why?
Adoptive Transfer
1
2012
195
0.020
 Why?
Endothelium
1
2012
111
0.020
 Why?
Quality Assurance, Health Care
1
2014
311
0.020
 Why?
Toll-Like Receptor 4
1
2014
287
0.020
 Why?
Cross-Over Studies
1
2013
440
0.020
 Why?
Epistasis, Genetic
1
2012
67
0.020
 Why?
General Surgery
1
2013
127
0.020
 Why?
Cell Survival
1
2014
1021
0.020
 Why?
Internal Medicine
1
2013
211
0.020
 Why?
Longitudinal Studies
1
2017
2387
0.020
 Why?
Microbial Viability
1
2011
79
0.020
 Why?
Arthroplasty, Replacement, Knee
1
2014
246
0.020
 Why?
Superoxides
1
2011
214
0.020
 Why?
Enzyme Activation
1
2012
785
0.020
 Why?
Interleukin-8
1
2011
237
0.020
 Why?
Viruses
1
2011
94
0.020
 Why?
Cell Separation
1
2011
291
0.020
 Why?
Single-Payer System
1
2009
2
0.020
 Why?
Species Specificity
1
2011
542
0.020
 Why?
Survivors
1
2013
411
0.020
 Why?
Disease-Free Survival
1
2011
620
0.020
 Why?
Cell Death
1
2011
323
0.020
 Why?
Administration, Inhalation
1
2011
641
0.020
 Why?
Case-Control Studies
1
2016
3003
0.020
 Why?
Nitric Oxide
1
2014
823
0.020
 Why?
Information Dissemination
1
2011
186
0.020
 Why?
Self Report
1
2013
696
0.020
 Why?
Advisory Committees
1
2010
208
0.020
 Why?
Drug Resistance, Bacterial
1
2009
155
0.020
 Why?
Cell Line
1
2014
2637
0.020
 Why?
Precision Medicine
1
2012
337
0.020
 Why?
Microbial Sensitivity Tests
1
2009
300
0.020
 Why?
Total Quality Management
1
2008
61
0.020
 Why?
Ventilator Weaning
1
2008
33
0.020
 Why?
Placebos
1
2008
197
0.020
 Why?
Neutrophil Infiltration
1
2008
96
0.020
 Why?
Capillary Permeability
1
2008
139
0.020
 Why?
United States Food and Drug Administration
1
2008
172
0.020
 Why?
Health Plan Implementation
1
2008
132
0.020
 Why?
Interdisciplinary Communication
1
2008
183
0.020
 Why?
Drug Industry
1
2008
103
0.020
 Why?
Tumor Necrosis Factor-alpha
1
2012
1140
0.020
 Why?
Dose-Response Relationship, Drug
1
2011
1842
0.020
 Why?
Chemokines
1
2008
216
0.020
 Why?
Acid-Base Equilibrium
1
2007
29
0.020
 Why?
Umbilical Veins
1
2006
58
0.020
 Why?
Cost Control
1
2006
39
0.020
 Why?
CD8 Antigens
1
2006
69
0.020
 Why?
Ketones
1
2007
44
0.020
 Why?
Medical Audit
1
2007
75
0.020
 Why?
Microcirculation
1
2007
135
0.020
 Why?
Receptors, Vascular Endothelial Growth Factor
1
2006
103
0.020
 Why?
Bacillus subtilis
1
2006
58
0.020
 Why?
CD4 Antigens
1
2006
123
0.020
 Why?
Information Management
1
2006
15
0.020
 Why?
Cell Count
1
2006
303
0.020
 Why?
Fluorescent Antibody Technique
1
2006
397
0.020
 Why?
Genome-Wide Association Study
1
2012
1177
0.020
 Why?
User-Computer Interface
1
2006
140
0.020
 Why?
Interleukin-10
1
2006
299
0.010
 Why?
Polymorphism, Single Nucleotide
1
2012
1880
0.010
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2007
238
0.010
 Why?
Asthma
1
2017
2029
0.010
 Why?
Inflammation Mediators
1
2006
477
0.010
 Why?
Hypoglycemia
1
2007
387
0.010
 Why?
Endothelium, Vascular
1
2007
847
0.010
 Why?
Cardiotonic Agents
1
2001
119
0.010
 Why?
Hypothermia, Induced
1
2001
66
0.010
 Why?
Mass Screening
1
2006
1004
0.010
 Why?
RNA, Messenger
1
2006
2553
0.010
 Why?
Hypoglycemic Agents
1
2007
1013
0.010
 Why?
Dopamine
1
2001
236
0.010
 Why?
Anti-Inflammatory Agents
1
2001
447
0.010
 Why?
Insulin
1
2007
2079
0.010
 Why?
Douglas's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (600) concept(s)
_
Co-Authors Expand Description
See all (60) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)